How Centaur Supports Your CMS Health Tech Ecosystem Pledge

In July 2025, more than 60 companies gathered at a White House event to make an initial pledge: real-time, interoperable, patient-first health data. The CMS Health Tech Ecosystem initiative had launched. Since then, that founding group of tech giants, health systems, payers, EHR vendors, and patient-facing app builders has grown to more than 700 organizations, all voluntarily aligning around a common framework to modernize how health information flows in America. That is not a small ask. And the clock is running.

‍

The initiative set two milestones: March 31 for a minimum viable product, and July 4 for advanced functionality. The first passed. The second is three weeks away. For most organizations, the pledge was the easy part. The hard part is what comes next: building, validating, and shipping AI that can actually survive clinical, regulatory, and procurement scrutiny before the milestone hits.

‍

Here is what we keep seeing across the pledge categories and where teams are losing time.

‍

Connected data is not the same as AI-ready data

This is the most common misconception we encounter. The CMS framework gets your data flowing: FHIR APIs, clinical documents, and real-time exchange between providers and payers. That is a genuine step forward.

But flowing data and AI-ready data are not the same thing. The part that quietly decides whether a model ships is the expert validation layer. De-identification that is defensible, not just automated. Annotation that captures clinical nuance, expert disagreement, and real-world edge cases. Evaluation that runs through credentialed professionals, not just internal QA.

‍

Teams do not lose time on the model. They lose it on data they cannot defend when procurement or a compliance team asks the hard questions.

‍

What "clinically defensible" actually means

Across the CMS pledge categories, the bar is the same even if the use case is different.

For conversational AI assistants, the CMS framework requires that patient-facing tools clearly distinguish educational content from clinical guidance, indicate when outputs are AI-generated, and connect to verified clinical records through CMS Aligned Networks. Meeting that standard means your model has been benchmarked against credentialed medical professionals, red-teamed for hallucinations and unsafe outputs, and evaluated with the kind of expert-adjudicated datasets that hold up to regulatory review. An assistant that sounds right and one that is right are very different products.

‍

For diabetes and obesity management, the CMS criteria require apps to use the clinical record to generate personalized coaching and risk alerts and to support both prevention and active management, including medication, lab trends, and nutrition tracking. That requires training data that reflects actual clinical nuance: glycemic variability, dietary behavior, comorbidity patterns, and the expert disagreement that real cases produce. Clean labels are not enough. The model needs to have seen the edges.

‍

For Kill the Clipboard, the CMS framework requires apps to transmit patient health history and insurance information via FHIR, retrieve visit records, and connect to CMS-aligned networks. That means your FHIR normalization, document extraction, and patient-journey models need to have been validated by someone other than your own team. Ingesting data from disparate sources is step one. Proving the AI layer on top of it is accurate is step two, and that step tends to get skipped until it is too late.

‍

For EHR vendors and data networks, the CMS requirements include sharing both structured FHIR data and unstructured clinical documents and delivering appointment and encounter notifications to connected networks within 24 hours. Connected data alone is not sufficient for AI deployment. Your pledgee customers need what sits on top of the data: expert annotation, de-identification that survives procurement scrutiny, and human-in-the-loop evaluation at scale.

‍

For health systems, the accountability runs in every direction at once: patients, boards, compliance teams, and regulators. The documentation of validation rigor matters as much as the validation itself.

‍

For payers, the CMS framework requires making claims data accessible to CMS-aligned networks and supporting electronic prior authorization workflows. Prior authorization AI and patient-facing tools require clinical validation that a procurement team can actually present and defend. Benchmarking against gold-standard labeled datasets is not optional when CMS is watching the track closely.

‍

Why the timeline is tighter than it looks

Three weeks is not much runway. For most organizations, the infrastructure work has been underway for months: FHIR-based data exchange, real-time notifications, and interoperability plumbing. The July 4 milestone is the moment that work goes live.

‍

What has not been underway for most organizations is the validation layer for the AI sitting on top of that infrastructure. That is the part that tends to get scoped for Q3 until the milestone is three weeks out and it becomes urgent.

‍

Three weeks is enough time. But only if the work starts now, and only if annotation, de-identification, and evaluation can happen in parallel rather than in sequence. Centaur's network of 100,000+ licensed clinicians and domain experts is built specifically to compress that timeline, running competitive annotation workflows that produce expert-adjudicated datasets faster than any sequential approach.

‍

What we are seeing work

The teams moving fastest are treating data quality as a competitive advantage rather than a compliance checkbox. They are sourcing expert disagreement intentionally, not filtering it out. They are running red-team evaluations before internal demos, not after. They are building the validation documentation alongside the model, not retrofitting it afterward.

‍

The teams that are behind are almost always behind on the same thing: good data infrastructure, a model that performs well in testing, but no expert-adjudicated evidence to make the AI defensible when scrutinized by a procurement team, a compliance officer, or a regulator.

‍

July 4 is a launchpad, not a finish line

The organizations that will win the next year of healthcare AI are not necessarily the ones who ship the most by July 4. They are the ones who ship something they can stand behind and keep improving, because the data pipeline feeding their models is built for it.

‍

Milestones like this create momentum. The teams that capitalize on that momentum are the ones who have already solved the validation problem and can move to the next model, the next use case, and the next deployment with confidence.

‍

If your July 4 deliverable depends on AI that needs to be clinically defensible, we would like to help you get there.

‍

To see how we can help you meet your July 4 goal, click here to set up a 20-minute demo